Connection
Todd Pitts to Oncogene Proteins v-abl
This is a "connection" page, showing publications Todd Pitts has written about Oncogene Proteins v-abl.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.154 |
|
|
|
-
Scott AJ, Song EK, Bagby S, Purkey A, McCarter M, Gajdos C, Quackenbush KS, Cross B, Pitts TM, Tan AC, Eckhardt SG, Fenton H, Arcaroli J, Messersmith WA. Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model. PLoS One. 2017; 12(11):e0187173.
Score: 0.154